Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Martin Ekwealor Pharmaceuticals, Inc., also known as M.E. Pharmaceuticals, is a pharmaceutical company based in Richmond, Indiana, that specialized in the manufacture and distribution of nutritional supplements and topical medications. Established in 1992, the company's product line included iron-based treatments such as Myferon 150 and Myferon 150 Forte, as well as Lidocaine Ointment and various vitamin formulations. The company primarily operated as a manufacturer and packager of generic and over-the-counter products, though its participation in federal rebate programs was terminated in the mid-2000s. Currently, the company appears to be inactive, with no active clinical pipeline or recent commercial expansions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Martin Ekwealor Pharmaceuticals.